Liver diseases are among the top global health burdens. Recently, there has been an increasing significance of diagnostics without discomfort to the patient; among them, ultrasound is the most used. Deep learning, in particular convolutional neural networks, has revolutionized the classification of liver diseases by automatically performing some specific analyses of difficult images. This review summarizes the progress that has been made in deep learning techniques for the classification of liver diseases using ultrasound imaging. It evaluates various models from CNNs to their hybrid versions, such as CNN-Transformer, for detecting fatty liver, fibrosis, and liver cancer, among others. Several challenges in the generalization of data and models across a different clinical environment are also discussed. Deep learning has great prospects for automatic diagnosis of liver diseases. Most of the models have performed with high accuracy in different clinical studies. Despite this promise, challenges relating to generalization have remained. Future hardware developments and access to quality clinical data continue to further improve the performance of these models and ensure their vital role in the diagnosis of liver diseases.

Periventricular white matter injury (PWMI) is the most frequent magnetic resonance imaging (MRI) finding in infants with Cerebral Palsy (CP). We aim to detect CP and identify subtle, sparse PWMI lesions in infants under two years of age with immature brain structures. Based on the characteristic that the responsible lesions are located within five target regions, we first construct a multi-modal dataset including 243 cases with the mask annotations of five target regions for delineating anatomical structures on T1-Weighted Imaging (T1WI) images, masks for lesions on T2-Weighted Imaging (T2WI) images, and categories (CP or Non-CP). Furthermore, we develop a bidirectional projection-based multi-modal fusion transformer (BiP-MFT), incorporating a Bidirectional Projection Fusion Module (BPFM) for integrating the features between five target regions on T1WI images and lesions on T2WI images. Our BiP-MFT achieves subject-level classification accuracy of 0.90, specificity of 0.87, and sensitivity of 0.94. It surpasses the best results of nine comparative methods, with 0.10, 0.08, and 0.09 improvements in classification accuracy, specificity and sensitivity respectively. Our BPFM outperforms eight compared feature fusion strategies using Transformer and U-Net backbones on our dataset. Ablation studies on the dataset annotations and model components justify the effectiveness of our annotation method and the model rationality. The proposed dataset and codes are available at https://github.com/Kai-Qi/BiP-MFT.

We present results of the development of Dentomo artificial intelligence model based on two neural networks. The model includes a database and a knowledge base harmonized with SNOMED CT that allows processing and interpreting the results of cone beam computed tomography (CBCT) scans of the dental system, in particular, identifying and classifying teeth, identifying CT signs of pathology and previous treatments. Based on these data, artificial intelligence can draw conclusions and generate medical reports, systematize the data, and learn from the results. The diagnostic effectiveness of Dentomo was evaluated. The first results of the study have demonstrated that the model based on neural networks and artificial intelligence is a valuable tool for analyzing CBCT scans in clinical practice and optimizing the dentist workflow.

Imaging is crucial to assess disease extent, activity, and outcomes in inflammatory bowel disease (IBD). Artificial intelligence (AI) image interpretation requires automated exploitation of studies at scale as an initial step. Here we evaluate natural language processing to classify Crohn's disease (CD) on CTE. From our population representative IBD registry a sample of CD patients (male: 44.6%, median age: 50 IQR37-60) and controls (n = 981 each) CTE reports were extracted and split into training- (n = 1568), development- (n = 196), and testing (n = 198) datasets each with around 200 words and balanced numbers of labels, respectively. Predictive classification was evaluated with CNN, Bi-LSTM, BERT-110M, LLaMA-3.3-70B-Instruct and DeepSeek-R1-Distill-LLaMA-70B. While our custom IBDBERT finetuned on expert IBD knowledge (i.e. ACG, AGA, ECCO guidelines), outperformed rule- and rationale extraction-based classifiers (accuracy 88.6% with pre-tuning learning rate 0.00001, AUC 0.945) in predictive performance, LLaMA, but not DeepSeek achieved overall superior results (accuracy 91.2% vs. 88.9%, F1 0.907 vs. 0.874).

Breast cancer is a serious public health problem and is one of the leading causes of cancer-related deaths in women worldwide. Early detection of the disease can significantly increase the chances of survival. However, manual analysis of mammogram mastery images is complex and time-consuming, which can lead to disagreements among experts. For this reason, automated diagnostic systems can play a significant role in increasing the accuracy and efficiency of diagnosis. In this study, we present an effective deep learning (DL) method, which classifies mammogram mastery images into cancer and noncancer categories using a collected dataset. Our model is pretrained based on the Inception V3 architecture. First, we run 5-fold cross-validation tests on the fully trained and fine-tuned Inception V3 model. Next, we apply a combined method based on likelihood and mean, where the fine-tuned Inception V3 model demonstrated superior performance in classification. Our DL model achieved 99% accuracy and 99% F1 score. In addition, interpretable AI techniques were used to enhance the transparency of the classification process. The finely tuned Inception V3 model demonstrated the highest performance in classification, confirming its effectiveness in automatic breast cancer detection. The experimental results clearly indicate that our proposed DL-based method for breast cancer image classification is highly effective, especially its application in image-based diagnostic methods. This study brings to the fore the huge potential of AI-based solutions, which can play a significant role in increasing the accuracy and reliability of breast cancer diagnosis.

Lung cancer remains a leading cause of cancer-related mortality worldwide, emphasizing the critical need for accurate and early diagnostic solutions. This study introduces a novel multimodal artificial intelligence (AI) framework that integrates Convolutional Neural Networks (CNNs) and Artificial Neural Networks (ANNs) to improve lung cancer classification and severity assessment. The CNN model, trained on 1019 preprocessed CT images, classified lung tissue into four histological categories, adenocarcinoma, large cell carcinoma, squamous cell carcinoma, and normal, with a weighted accuracy of 92 %. Interpretability is enhanced using Gradient-weighted Class Activation Mapping (Grad-CAM), which highlights the salient image regions influencing the model's predictions. In parallel, an ANN trained on clinical data from 999 patients-spanning 24 key features such as demographic, symptomatic, and genetic factors-achieves 99 % accuracy in predicting cancer severity (low, medium, high). SHapley Additive exPlanations (SHAP) are employed to provide both global and local interpretability of the ANN model, enabling transparent decision-making. Both models were rigorously validated using k-fold cross-validation to ensure robustness and reduce overfitting. This hybrid approach effectively combines spatial imaging data and structured clinical information, demonstrating strong predictive performance and offering an interpretable and comprehensive AI-based solution for lung cancer diagnosis and management.

Echocardiography is the most common modality for assessing cardiac structure and function. While cardiac magnetic resonance (CMR) imaging is less accessible, CMR can provide unique tissue characterization including late gadolinium enhancement (LGE), T1 and T2 mapping, and extracellular volume (ECV) which are associated with tissue fibrosis, infiltration, and inflammation. Deep learning has been shown to uncover findings not recognized by clinicians, however it is unknown whether CMR-based tissue characteristics can be derived from echocardiography videos using deep learning. To assess the performance of a deep learning model applied to echocardiography to detect CMR-specific parameters including LGE presence, and abnormal T1, T2 or ECV. In a retrospective single-center study, adult patients with CMRs and echocardiography studies within 30 days were included. A video-based convolutional neural network was trained on echocardiography videos to predict CMR-derived labels including LGE presence, and abnormal T1, T2 or ECV across echocardiography views. The model was also trained to predict presence/absence of wall motion abnormality (WMA) as a positive control for model function. The model performance was evaluated in a held-out test dataset not used for training. The study population included 1,453 adult patients (mean age 56±18 years, 42% female) with 2,556 paired echocardiography studies occurring at a median of 2 days after CMR (interquartile range 2 days prior to 6 days after). The model had high predictive capability for presence of WMA (AUC 0.873 [95%CI 0.816-0.922]) which was used for positive control. However, the model was unable to reliably detect the presence of LGE (AUC 0.699 [0.613-0.780]), abnormal native T1 (AUC 0.614 [0.500-0.715]), T2 0.553 [0.420-0.692], or ECV 0.564 [0.455-0.691]). Deep learning applied to echocardiography accurately identified CMR-based WMA, but was unable to predict tissue characteristics, suggesting that signal for these tissue characteristics may not be present within ultrasound videos, and that the use of CMR for tissue characterization remains essential within cardiology.

Atypia of Undetermined Significance (AUS), classified as Category III in the Bethesda Thyroid Cytopathology Reporting System, presents significant diagnostic challenges for clinicians. This study aims to develop a clinical decision support system that integrates structural equation modeling (SEM) and machine learning to predict malignancy in AUS thyroid nodules. The model integrates preoperative clinical data, ultrasonography (USG) findings, and cytopathological and morphometric variables. This retrospective cohort study was conducted between 2011 and 2019 at Karadeniz Technical University (KTU) Farabi Hospital. The dataset included 56 variables derived from 204 thyroid nodules diagnosed via ultrasound-guided fine-needle aspiration biopsy (FNAB) in 183 patients over 18 years. Logistic regression (LR) and SEM were used to identify risk factors for early thyroid cancer detection. Subsequently, machine learning algorithms-including Support Vector Machines (SVM), Naive Bayes (NB), and Decision Trees (DT) were used to construct decision support models. After feature selection with SEM, the SVM model achieved the highest performance, with an accuracy of 82 %, a specificity of 97 %, and an AUC value of 84 %. Additional models were developed for different scenarios, and their performance metrics were compared. Accurate preoperative prediction of malignancy in thyroid nodules is crucial for avoiding unnecessary surgeries. The proposed model supports more informed clinical decision-making by effectively identifying benign cases, thereby reducing surgical risk and improving patient care.

Due to imbalanced data values and high-dimensional features of lung cancer from CT scans images creates significant challenges in clinical research. The improper classification of these images leads towards higher complexity in classification process. These critical issues compromise the extraction of biomedical traits and also design incomplete classification of lung cancer. As the conventional approaches are partially successful in dealing with the complex nature of high-dimensional and imbalanced biomedical data for lung cancer classification. Thus, there is a crucial need to develop a robust classification technique which can address these major concerns in the classification of lung cancer images. In this paper, we propose a novel structural formation of the oblique decision tree (OBT) using a swarm intelligence technique, namely, the Binary Bat Swarm Algorithm (BBSA). The application of BBSA enables a competitive recognition rate to make structural reforms while building OBT. Such integration improves the ability of the machine learning swarm classifier (MLSC) to handle high-dimensional features and imbalanced biomedical datasets. The adaptive feature selection using BBSA allows for the exploration and selection of relevant features required for classification from ODT. The ODT classifier introduces flexibility in decision boundaries, which enables it to capture complex linkages between biomedical data. The proposed MLSC model effectively handles high-dimensional, imbalanced lung cancer datasets using TCGA_LUSC_2016 and TCGA_LUAD_2016 modalities, achieving superior precision, recall, F-measure, and execution efficiency. The experiments are conducted in Python to evaluate the performance metrics that consistently demonstrate enhanced classification accuracy and reduced misclassification rates compared to existing methods. The MLSC is assessed in terms of both qualitative and quantitative measurements to study the capability of the proposed MLSC in classifying the instances more effectively than the conventional state-of-the-art methods.